UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023142
Receipt number R000026680
Scientific Title The effect of staple food (rice or bread) for intestinal flora in healthy people
Date of disclosure of the study information 2016/07/13
Last modified on 2019/07/17 12:02:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of staple food (rice or bread) for intestinal flora in healthy people

Acronym

The effect of staple food for intestinal flora

Scientific Title

The effect of staple food (rice or bread) for intestinal flora in healthy people

Scientific Title:Acronym

The effect of staple food for intestinal flora

Region

Japan


Condition

Condition

healthy people

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To study the effect of staple food for intestinal flora.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

hydrogen in the breath by 1 week

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

healthy person, who has no commonly used drugs, who has not been pointed out an anomaly in the health diagnosis for past one year.

Key exclusion criteria

If the consent can not be obtained,
Who has underlying disease,
Who has commonly used drugs,
Who has food allergy,
Who used intestinal drugs or antibiotics during the study period,
Who had obvious poor health such as diarrhea or fever during the study period.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaori Ikeda

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Diabetes, Endocrinology and Nutrition

Zip code


Address

54, Kawaramachi, Shougoin, Sakyo-ku, Kyoto city, Kyoto, Japan

TEL

075-751-3560

Email

krikeda@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kaori Ikeda

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Diabetes, Endocrinology and Nutrition

Zip code


Address

54, Kawaramachi, Shougoin, Sakyo-ku, Kyoto city, Kyoto, Japan

TEL

075-751-3560

Homepage URL


Email

krikeda@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Agriculture, Forestry and Fisheries

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 13 Day


Related information

URL releasing protocol

https://www.mdpi.com/2072-6643/10/9/1323

Publication of results

Unpublished


Result

URL related to results and publications

https://www.mdpi.com/2072-6643/10/9/1323

Number of participants that the trial has enrolled

10

Results

After the bread period, the abundance of fecal Bifidobacterium genus, fasting glucagon-like peptide 1, and breath hydrogen were significantly higher than those of after the rice period. Plasma SCFAs also tended to be higher after the bread period.

Results date posted

2019 Year 07 Month 17 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

healthy subjects

Participant flow

a total of seven subjects

Adverse events

Nothing

Outcome measures

the abundance of fecal Bifidobacterium genus
fasting glucagon-like peptide 1
breath hydrogen

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 07 Month 13 Day

Date of IRB

2016 Year 04 Month 20 Day

Anticipated trial start date

2016 Year 08 Month 15 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2016 Year 07 Month 13 Day

Last modified on

2019 Year 07 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026680

Research Plan
Registered date File name
2019/01/14 研究計画書米飯.docx
Research case data specifications
Registered date File name
2019/01/14 説明.docx
Research case data
Registered date File name
2019/01/14 対応のあるt検定用採血結果.jmp

Single case data URL

Value
https://center6.umin.ac.jp/ice/26680